Icecure Competitors

Stocks . USA . 
Stock . Icecure Medical
ICCM Stock  USD 0.57  0.02  3.39%   
Icecure Medical competes with Spectral, Cytosorbents Crp, Tela Bio, Sensus Healthcare, and Telomir Pharmaceuticals; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Icecure Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Icecure Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Icecure Medical Correlation with its peers.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.

Icecure Medical vs PetMed Express Correlation

Very good diversification

The correlation between Icecure Medical and PETS is -0.45 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Icecure Medical and PETS in the same portfolio, assuming nothing else is changed.

Moving together with Icecure Stock

  0.62IL3 Integra LifeSciencesPairCorr

Moving against Icecure Stock

  0.74EDAP EDAP TMS SAPairCorr
  0.69EKSO Ekso Bionics HoldingsPairCorr
  0.64HYB HOYAPairCorr
  0.44VREX Varex Imaging CorpPairCorr
  0.44SKAN SKAN Group AGPairCorr
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Icecure Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.583.80
Details
Intrinsic
Valuation
LowRealHigh
0.061.194.41
Details

Icecure Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Icecure Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Icecure and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Icecure Medical does not affect the price movement of the other competitor.

High positive correlations

BDMD
+ 0.92
TELA
MDCX
+ 0.85
BDMD
MDCX
+ 0.82
TELA
ECOR
+ 0.81
SRTS
TELO
+ 0.8
TELA
BDMD
+ 0.75
TELO
  

High negative correlations

PETS
- 0.68
MDCX
MDCX
- 0.64
SRTS
BDMD
- 0.6
SRTS
SRTS
- 0.6
TELA
ECOR
- 0.57
BDMD
MDCX
- 0.55
ECOR

Risk-Adjusted Indicators

There is a big difference between Icecure Stock performing well and Icecure Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Icecure Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MDAI  3.07  0.12  0.03  0.17  3.76 
(3.22)
 6.29 
(6.87)
 17.06 
CTSO  3.68 (0.01) 0.00  0.05  4.14 
(5.20)
 7.94 
(7.41)
 29.40 
TELA  2.53 (0.59) 0.00 (0.85) 0.00 
 0.00 
 4.42 
(5.61)
 19.20 
SRTS  3.01 (0.18) 0.00 (0.06) 0.00 
 0.00 
 7.57 
(6.04)
 21.38 
TELO  2.53 (0.45) 0.00 (0.27) 0.00 
 0.00 
 3.15 
(4.55)
 17.75 
BDMD  3.23 (0.76) 0.00 (4.70) 0.00 
 0.00 
 8.67 
(8.00)
 21.01 
ECOR  3.78  0.02  0.02  0.07  4.40 
(4.15)
 9.10 
(7.53)
 21.08 
MDCX  3.74 (1.18) 0.00 (4.51) 0.00 
 0.00 
 6.77 
(8.93)
 21.20 
VNRX  4.71 (0.28) 0.00  0.28  0.00 
 0.00 
 10.71 
(9.37)
 32.69 
PETS  4.83  1.05  0.36  0.49  2.81 
(8.54)
 8.59 
(5.10)
 73.96 

Icecure Medical Competitive Analysis

The better you understand Icecure Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Icecure Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Icecure Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ICCM MDAI CTSO TELA SRTS TELO BDMD ECOR MDCX VNRX
 3.39 
 0.57 
Icecure
 2.65 
 1.55 
Spectral
 3.23 
 0.64 
Cytosorbents
 3.66 
 0.79 
Tela
 16.99 
 3.86 
Sensus
 0.93 
 1.09 
Telomir
 3.75 
 0.77 
Baird
 2.86 
 5.43 
Electrocore
 7.07 
 1.06 
Medicus
 4.17 
 0.23 
Volitionrx
Market Volatility
(90 Days Market Risk)
Dangerous
Very risky
Dangerous
Dangerous
Relatively risky
Moderately volatile
Abnormally volatile
Slightly risky
Extremely Dangerous
Abnormally volatile
Market Performance
(90 Days Performance)
Weakest
Soft
Weak
Weakest
Weakest
Weakest
Weakest
Weak
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Small
Risky
Risky
Risky
Low
High
Fair
Risky
High
Risky
Current Valuation
(Equity Enterprise Value)
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Over Valued
Under Valued
Fairly Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Strong Buy
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Hold
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Current Ratio
4.99
N/A
3.95
3.83
5.01
N/A
N/A
5.16
0.53
1.04
Net Asset
12.58 M
12.1 M
47.37 M
87.33 M
53.04 M
1.32 M
77.96 M
20.47 M
5.65 M
9.4 M
Profit Margin
N/A
-0.71
-0.28
-0.51
-0.0844
N/A
-0.0995
-0.47
N/A
N/A
EBITDA
(15.36 M)
(11.49 M)
(15.22 M)
(31.68 M)
(9.92 M)
48 K
16.17 M
(10.9 M)
(323.24 K)
(25.58 M)
Operating Margin
-4.51
-0.88
-0.28
-0.37
0.41
N/A
-1.31
-0.33
N/A
-8.13
Current Valuation
29.8 M
46.43 M
59.48 M
49.01 M
51.96 M
37.06 M
51.24 M
42.4 M
26.34 M
42.64 M
Price To Book
4.25
29.88
4.42
23.46
1.48
5.3
0.87
34.89
15.81
38.44
Retained Earnings
(105.38 M)
(48.1 M)
(304.01 M)
(358.73 M)
5.71 M
(30.6 M)
26.76 M
(177.09 M)
(28.9 M)
(229.54 M)
Current Asset
N/A
N/A
9.05 M
N/A
N/A
N/A
N/A
21.97 M
N/A
6.22 M
Five Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
2.21
0.95
1.41
0.87
1.19
-0.48
-1.08
0.51
-1.73
1.3
Number Of Employees
64
78
149
209
54
7
143
73
11
75
Shares Outstanding
68.96 M
30.69 M
62.8 M
44.53 M
16.43 M
34.38 M
36.73 M
8 M
24.71 M
135.57 M
Cash Flow From Operations
(12.56 M)
(9.2 M)
(14.43 M)
(41.59 M)
(831 K)
(5.07 M)
(6.31 M)
(6.95 M)
(10.25 M)
(25.89 M)
Total Debt
459 K
4.69 M
26.89 M
43.06 M
680 K
93.43 K
20.88 M
4.14 M
2.51 M
5.82 M
Return On Equity
-1.58
-23.08
-0.93
-6.76
-0.0571
-3.03
-0.0803
-3.38
-26.61
-7.3
Return On Asset
-0.63
-0.35
-0.19
-0.39
-0.0575
-1.67
-0.002
-0.39
-1.71
-1.48
Number Of Shares Shorted
548.03 K
1.48 M
2.04 M
508.38 K
579.39 K
1.45 M
37.63 K
270 K
888.65 K
1.57 M
Book Value Per Share
0.14
-0.3
0.14
0.039
1.57
0.21
1.34
-0.14
-0.043
-0.32
Current Liabilities
N/A
N/A
5 M
N/A
N/A
N/A
N/A
5.85 M
N/A
1.12 M
Total Asset
12.58 M
12.1 M
47.37 M
87.33 M
53.04 M
1.32 M
77.96 M
20.47 M
5.65 M
9.4 M
Debt To Equity
0.039
N/A
0.28
3.33
0.024
N/A
N/A
0.026
N/A
1.57
Short Ratio
1.83
4.09
23.21
7.95
4.86
8.34
0.29
2.9
2.97
0.65
Target Price
3.13
5.36
5.25
3.45
7.33
15.5
N/A
19.75
20.03
2.2
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
0.77
10.66
26.0
75.62
28.5
6.92
1.13
10.8
12.16
25.04
Market Capitalization
39.52 M
46.34 M
40.28 M
34.99 M
76.45 M
37.13 M
29.38 M
43.42 M
29.8 M
30.73 M
Price To Earning
N/A
N/A
-16.3
N/A
4.3
N/A
N/A
-4.71
-0.21
-4.52
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
13.28
2.0
1.09
0.45
2.15
N/A
0.92
1.46
N/A
20.88
Net Income
(15.32 M)
(15.31 M)
(20.72 M)
(37.84 M)
6.65 M
(16.53 M)
12.6 M
(11.89 M)
(11.16 M)
(27.26 M)
Earnings Per Share
-0.25
-0.75
-0.18
-0.83
-0.18
-0.37
-0.11
-1.71
-2.14
-0.23
Shares Owned By Insiders
40.4
25.64
15.6
8.44
18.25
44.98
69.52
36.62
28.95
16.07
Revenue
3.29 M
29.58 M
35.59 M
69.3 M
27.48 M
N/A
37.04 M
25.18 M
N/A
1.23 M
Working Capital
5.24 M
(7.52 M)
11.78 M
62.47 M
50.85 M
643.04 K
26.79 M
7.15 M
3.07 M
(3.73 M)
Cash And Equivalents
17.73 M
N/A
30.16 M
27.73 M
33.7 M
N/A
N/A
26.33 M
1.22 K
16.42 M
Cash Per Share
0.48
N/A
0.69
1.9
2.04
N/A
N/A
0.37
N/A
0.28
Gross Profit
1.04 M
10.43 M
26.18 M
52.19 M
17.08 M
N/A
27.7 M
25.67 M
N/A
1.47 M
Day Typical Price
0.57
1.55
0.65
0.8
3.77
1.09
0.79
5.59
1.07
0.22
Accumulation Distribution
0.0508
0.044
0.0597
0.11
42047.83
0.0536
0.11
0.0861
0.16
0.087
Market Facilitation Index
0.03
0.07
0.04
0.09
0.0
0.06
0.09
0.51
0.18
0.02
Daily Balance Of Power
(0.67)
0.5714
0.5
(0.33)
(2.26)
0.1667
(0.33)
(0.31)
0.3889
(0.50)
Period Momentum Indicator
(0.02)
0.04
0.02
(0.03)
(0.79)
0.01
(0.03)
(0.16)
0.07
(0.01)
Rate Of Daily Change
0.97
1.03
1.03
0.96
0.83
1.01
0.96
0.97
1.07
0.96
Day Median Price
0.57
1.56
0.65
0.81
3.72
1.09
0.81
5.67
1.07
0.22
Price Action Indicator
(0.01)
0.015
N/A
(0.03)
(0.26)
0.005
(0.05)
(0.32)
0.025
0.005
Coefficient Of Variation
(1,046)
1989.44
5824.32
(622.69)
(5,744)
(937.00)
(602.85)
2905.94
(410.14)
(1,780)
Mean Deviation
2.49
3.07
3.68
2.53
3.01
2.53
3.23
3.78
3.74
4.71
Jensen Alpha
(0.42)
0.1172
(0.01)
(0.59)
(0.18)
(0.45)
(0.76)
0.018
(1.18)
(0.28)
Total Risk Alpha
(0.56)
(0.10)
(0.33)
(0.80)
(0.42)
(0.61)
(1.09)
(0.20)
(1.51)
(0.83)
Sortino Ratio
N/A
0.0321
0.0049
N/A
N/A
N/A
N/A
0.0214
N/A
N/A
Downside Variance
N/A
14.82
27.3
N/A
N/A
N/A
N/A
20.88
N/A
N/A
Standard Deviation
3.22
3.85
5.55
3.38
4.48
3.33
4.48
4.87
4.72
6.26
Kurtosis
0.4547
(0.14)
3.54
1.52
3.84
2.0
0.9172
0.0911
(0.26)
1.18
Potential Upside
4.35
6.29
7.94
4.42
7.57
3.15
8.67
9.1
6.77
10.71
Treynor Ratio
(0.19)
0.1657
0.0541
(0.85)
(0.06)
(0.27)
(4.70)
0.0677
(4.51)
0.2759
Maximum Drawdown
14.72
17.06
29.4
19.2
21.38
17.75
21.01
21.08
21.2
32.69
Variance
10.4
14.84
30.8
11.43
20.08
11.07
20.11
23.75
22.29
39.15
Market Risk Adjusted Performance
(0.18)
0.1757
0.0641
(0.84)
(0.05)
(0.26)
(4.69)
0.0777
(4.50)
0.2859
Risk Adjusted Performance
(0.07)
0.0485
0.0224
(0.12)
(0.01)
(0.08)
(0.13)
0.0361
(0.19)
(0.04)
Skewness
0.2503
0.0377
1.25
0.0852
0.0624
0.2809
0.538
0.3768
0.1372
0.7702
Semi Deviation
N/A
3.76
4.14
N/A
N/A
N/A
N/A
4.4
N/A
N/A
Information Ratio
(0.12)
0.0321
0.0046
(0.18)
(0.03)
(0.13)
(0.18)
0.0201
(0.26)
(0.07)
Value At Risk
(5.88)
(6.88)
(7.41)
(5.61)
(6.04)
(4.55)
(8.00)
(7.53)
(8.93)
(9.38)
Expected Short fall
N/A
(3.22)
(5.20)
N/A
N/A
N/A
N/A
(4.15)
N/A
N/A
Downside Deviation
N/A
3.85
5.23
N/A
N/A
N/A
N/A
4.57
N/A
N/A
Semi Variance
N/A
14.11
17.15
N/A
N/A
N/A
N/A
19.36
N/A
N/A

Icecure Medical Competition Performance Charts

Five steps to successful analysis of Icecure Medical Competition

Icecure Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Icecure Medical in relation to its competition. Icecure Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Icecure Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Icecure Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Icecure Medical, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Icecure Medical position

In addition to having Icecure Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Dividend Beast Thematic Idea Now

Dividend Beast
Dividend Beast Theme
An experimental equal-weighted theme of equities with high dividend yield and solid fundamentals based on Macroaxis rating system. The Dividend Beast theme has 69 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Dividend Beast Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Icecure Medical is a strong investment it is important to analyze Icecure Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icecure Medical's future performance. For an informed investment choice regarding Icecure Stock, refer to the following important reports:
How To Invest In Icecure
Details
Is Icecure Stock a good investment?
Details
What is Icecure Medical's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out Icecure Medical Correlation with its peers.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Will Health Care Equipment & Supplies sector continue expanding? Could Icecure diversify its offerings? Factors like these will boost the valuation of Icecure Medical. Market participants price Icecure higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Icecure Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Icecure Medical requires distinguishing between market price and book value, where the latter reflects Icecure's accounting equity. The concept of intrinsic value - what Icecure Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Icecure Medical's price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Icecure Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY